United States: Yearly Stock Market Performance Insight - 2009

Yearly Gainers
1,726
Yearly Losers
558
Average Return
82.69%
Total Stocks
2,336
View Detailed Market Cap Breakdown
Market CapYearly GainersYearly LosersAverage ReturnTotal Stocks
Mega Cap 32 8 45.62% 41
Large Cap 450 61 49.75% 518
Mid Cap 393 122 59.44% 523
Small Cap 151 56 55.60% 213

Yearly Streak Leaders for 2009

Stock Streak Streak Return
7 years โ†‘ 286.15%

McDonald's solidifies its market leadership with a 7-year growth streak (16.17 โ†’ 62.44), delivering 286.1% cumulative returns. Annual financials validate this performance: 6.0B revenue generating 1.9B net profit (31.4% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

3 years โ†‘ 112.13%

Netflix maintains steady growth trajectory with a 3-year growth streak (3.71 โ†’ 7.87), delivering 112.1% cumulative returns. Annual financials validate this performance: 10.5B revenue generating 2.9B net profit (27.4% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

3 years โ†“ -59.56%

General Electric sees continued yearly losses with a 3-year decline (179.29 โ†’ 72.51), down 59.6% cumulatively. Yet fundamentals remain solid: 9.9B annual revenue generating 2.0B profit (19.9% margin) as of Qtr ending Mar 2025 suggests this could be a value opportunity. Contrarian investors take note.

3 years โ†“ -24.88%

Wells Fargo encounters consecutive annual declines with a 3-year decline (35.93 โ†’ 26.99), down 24.9% cumulatively. Weak margins on 20.1B annual revenue with only 4.8B profit (23.8% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.

9 years โ†‘ 251.46%

Wabtec solidifies its market leadership with a 9-year growth streak (5.81 โ†’ 20.42), delivering 251.5% cumulative returns. Annual financials validate this performance: 2.6B revenue generating 327.0M net profit (12.5% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

8 years โ†‘ 1,025.21%

Stifel Financial continues its impressive multi-year expansion with a 8-year growth streak (2.34 โ†’ 26.33), delivering 1,025.2% cumulative returns. With 1.2B annual revenue generating only 53.0M profit (4.3% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

6 years โ†“ -53.76%

Marsh & McLennan faces prolonged challenges with a 6-year decline (47.75 โ†’ 22.08), down 53.8% cumulatively. Yet fundamentals remain solid: 7.1B annual revenue generating 1.4B profit (20.0% margin) as of Qtr ending Mar 2025 suggests this could be a value opportunity. Contrarian investors take note.

5 years โ†“ -62.52%

East West Bancorp faces prolonged challenges with a 5-year decline (42.16 โ†’ 15.80), down 62.5% cumulatively. Weak margins on 683.3M annual revenue with only 290.3M profit (42.5% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.

6 years โ†‘ 396.44%

Balchem continues its impressive multi-year expansion with a 6-year growth streak (4.50 โ†’ 22.34), delivering 396.4% cumulative returns. Annual financials validate this performance: 250.5M revenue generating 37.1M net profit (14.8% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

5 years โ†‘ 84.60%

Hawkins solidifies its market leadership with a 5-year growth streak (5.91 โ†’ 10.91), delivering 84.6% cumulative returns. Financial performance supports steady gains with 245.3M annual revenue yielding 16.3M profit (Qtr ending Mar 2025). The 6.7% margin provides buffer for continued expansion.

6 years โ†“ -92.91%

Kratos Defense faces prolonged challenges with a 6-year decline (148.90 โ†’ 10.55), down 92.9% cumulatively. Weak margins on 302.6M annual revenue with only 4.5M profit (1.5% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.

6 years โ†“ -85.33%

Ligand faces prolonged challenges with a 6-year decline (55.36 โ†’ 8.12), down 85.3% cumulatively. Financial struggles compound yearly losses: despite 45.3M annual revenue, - 42.5M losses persist (-93.6% margin) as of Qtr ending Mar 2025. Turnaround remains elusive.

5 years โ†‘ 166.67%

Stepan Company continues its impressive multi-year expansion with a 5-year growth streak (12.15 โ†’ 32.40), delivering 166.7% cumulative returns. With 525.6M annual revenue generating only 3.4M profit (0.6% margin) in Qtr ending Dec 2024, the market prices in significant margin expansion ahead.

2 years โ†‘ 106.85%

Steven Madden achieves gains with a 2-year growth streak (3.94 โ†’ 8.15), delivering 106.9% cumulative returns. With 553.5M annual revenue generating only 41.3M profit (7.5% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

5 years โ†“ -60.24%

QCR Holdings endures extended market pressure with a 5-year decline (21.00 โ†’ 8.35), down 60.2% cumulatively. Weak margins on 74.6M annual revenue with only 25.8M profit (34.6% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.

4 years โ†“ -76.92%

Stewart Information struggles through multi-year headwinds with a 4-year decline (48.87 โ†’ 11.28), down 76.9% cumulatively. Weak margins on 612.0M annual revenue with only 5.4M profit (0.9% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.

United States Market Yearly Gainers & Losers: 2009

Top United States Stock Gainers (2009)

StockYear OpenYear CloseYearly ChangeAvg Daily VolumeYear Volume
$2.19 $9.68 348.15% 23.47M 5.91B
$2.57 $6.73 162.89% 170.31M 42.92B
$3.07 $7.53 146.89% 568.47M 143.25B
$0.20 $0.47 135.00% 767.93M 193.52B
$8.02 $18.44 130.50% 8.69M 2.19B
$0.67 $8.90 1,312.70% 436.03K 109.88M
$4.95 $34.97 610.77% 6.88M 1.73B
$1.42 $8.20 540.63% 898.09K 226.32M
$0.80 $5.06 532.50% 23.20K 5.85M
$0.57 $3.39 494.74% 90.99K 22.93M
$0.71 $13.12 1,774.29% 2.59M 652.10M
$0.75 $10.84 1,364.86% 2.06M 519.95M
$0.35 $3.78 1,119.35% 571.36K 143.98M
$0.55 $6.46 1,013.79% 72.01K 18.15M
$0.67 $4.05 694.12% 48.03K 12.10M
$0.20 $2.64 1,366.67% 374.27K 94.32M
$3.20 $21.80 581.25% 8 2.06K
$6.34 $33.04 421.14% 552.34K 139.19M
$1.08 $5.39 390.00% 80.56K 20.30M
$2.17 $9.53 339.17% 685.39K 172.72M

Biggest United States Stock Losers (2009)

StockYear OpenYear CloseYearly ChangeAvg Daily VolumeYear Volume
$29.86 $15.26 -48.62% 3.22M 810.84M
$80.06 $68.19 -14.58% 28.70M 7.23B
$40.38 $35.71 -11.32% 6.65M 1.67B
$29.18 $26.99 -8.45% 95.98M 24.19B
$79.12 $72.51 -6.61% 24.55M 6.19B
$7.88 $3.65 -52.35% 24.38M 6.14B
$7.10 $6.70 -52.31% 111.82K 28.18M
$68.70 $33.10 -50.67% 51.49M 12.98B
$15.75 $10.12 -38.10% 490.50K 123.61M
$8.49 $5.55 -34.86% 20.71M 5.22B
$81.75 $9.05 -88.90% 340.34K 85.77M
$165.75 $34.50 -79.35% 68.69K 17.31M
$54.87 $11.67 -78.67% 61.06K 15.39M
$59.01 $14.35 -75.30% 1.46M 367.16M
$33.45 $8.15 -75.30% 42.10K 10.61M
$29.55 $9.00 -70.00% 5.17K 1.30M
$7.75 $6.87 -67.39% 29.94K 7.54M
$12.39 $4.65 -62.44% 575.79K 145.10M
$21.90 $8.89 -59.28% 51.19K 12.90M
$8.00 $9.11 -58.59% 534 134.50K

Most Active United States Stocks During 2009

StockYear OpenYear CloseYearly ChangeAvg Daily VolumeYearly Volume
$0.20 $0.47 135.00% 767.93M 193.52B
$3.07 $7.53 146.89% 568.47M 143.25B
$13.92 $15.06 6.96% 331.98M 83.66B
$2.57 $6.73 162.89% 170.31M 42.92B
$7.72 $15.52 101.56% 140.23M 35.34B
$2.30 $10.00 336.68% 76.44M 19.26B
$14.69 $20.40 39.15% 64.32M 16.21B
$16.96 $17.26 2.74% 58.88M 14.84B
$3.62 $5.39 49.31% 56.28M 14.18B
$68.70 $33.10 -50.67% 51.49M 12.98B
$13.65 $9.12 -33.72% 23.64M 5.96B
$40.71 $67.54 66.44% 18.96M 4.78B
$2.89 $11.35 301.06% 18.62M 4.69B
$10.44 $16.76 61.93% 12.70M 3.20B
$2.81 $3.66 30.25% 12.44M 3.13B
$1.60 $2.12 37.66% 28.54M 7.19B
$6.92 $5.45 -23.24% 7.42M 1.87B
$9.35 $16.98 81.41% 5.36M 1.35B
$10.10 $16.19 61.90% 5.06M 1.28B
$3.24 $6.03 89.03% 5.05M 1.27B

United States Sector Performance During 2009

Healthcare

167.57%
297 stocks
Top Performers by Market Cap:

Communication Services

164.57%
85 stocks
Top Performers by Market Cap:

Basic Materials

153.89%
145 stocks
Top Performers by Market Cap:
Mega Cap: LIN +35.29%
Large Cap: TECK +610.77%
Small Cap: SKE +581.25%

Technology

121.57%
303 stocks
Top Performers by Market Cap:

Consumer Cyclical

104.58%
263 stocks
Top Performers by Market Cap:
Mega Cap: AMZN +162.89%
Large Cap: F +336.68%
Small Cap: TRS +390.00%

Consumer Defensive

75.43%
113 stocks
Top Performers by Market Cap:
Mega Cap: KO +25.88%
Large Cap: PPC +1,312.70%
Small Cap: ANDE +56.60%

Energy

62.60%
112 stocks
Top Performers by Market Cap:

Industrials

42.73%
368 stocks
Top Performers by Market Cap:

Real Estate

36.73%
126 stocks
Top Performers by Market Cap:
Large Cap: CBRE +214.12%
Small Cap: DRH +67.06%

Utilities

20.05%
63 stocks
Top Performers by Market Cap:
Large Cap: CMS +54.90%
Mid Cap: AES +61.53%
Small Cap: MSEX +2.26%

Financial Services

10.09%
437 stocks
Top Performers by Market Cap:
Mega Cap: AXP +118.44%
Large Cap: BMO +106.62%
Small Cap: WT +164.29%

Data is updated regularly. Yearly performance is calculated based on closing prices.